Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

CGTX

Cognition Therapeutics (CGTX)

Cognition Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CGTX
DateTimeSourceHeadlineSymbolCompany
07/05/202421:45Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CGTXCognition Therapeutics Inc
07/05/202421:39Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CGTXCognition Therapeutics Inc
12/03/202407:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CGTXCognition Therapeutics Inc
12/03/202407:06Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CGTXCognition Therapeutics Inc
21/02/202408:44Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CGTXCognition Therapeutics Inc
21/02/202408:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CGTXCognition Therapeutics Inc
21/02/202408:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CGTXCognition Therapeutics Inc
10/02/202411:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CGTXCognition Therapeutics Inc
20/01/202407:07Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CGTXCognition Therapeutics Inc
09/01/202416:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CGTXCognition Therapeutics Inc
09/01/202408:11Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:CGTXCognition Therapeutics Inc
05/01/202408:21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CGTXCognition Therapeutics Inc
04/01/202423:30GlobeNewswire Inc.Cognition Therapeutics CEO Issues Letter to ShareholdersNASDAQ:CGTXCognition Therapeutics Inc
30/12/202308:02Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CGTXCognition Therapeutics Inc
16/11/202323:30GlobeNewswire Inc.Cognition Therapeutics Releases New Episode of “Conversations” Podcast Recorded at CTAD with Quantitative EEG Experts, Drs Willem de Haan and Philip ScheltensNASDAQ:CGTXCognition Therapeutics Inc
15/11/202323:30GlobeNewswire Inc.Cognition Therapeutics Presents Preclinical Data Identifying Pathways Impacted by Sigma-2 Receptor Modulators in Alzheimer’s and Parkinson’s DiseasesNASDAQ:CGTXCognition Therapeutics Inc
14/11/202309:25Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:CGTXCognition Therapeutics Inc
14/11/202309:17Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CGTXCognition Therapeutics Inc
14/11/202301:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CGTXCognition Therapeutics Inc
14/11/202301:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CGTXCognition Therapeutics Inc
07/11/202323:30GlobeNewswire Inc.Cognition Therapeutics Completes Enrollment in Phase 2 SHINE Study of CT1812 in Mild-to-Moderate Alzheimer’s DiseaseNASDAQ:CGTXCognition Therapeutics Inc
02/11/202322:45Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CGTXCognition Therapeutics Inc
02/11/202322:41Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CGTXCognition Therapeutics Inc
02/11/202322:30GlobeNewswire Inc.Cognition Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:CGTXCognition Therapeutics Inc
27/10/202322:30GlobeNewswire Inc.Cognition Therapeutics and Collaborators at Yale and ACTC Announce Oral Late-breaking Presentation on the START Study in Early Alzheimer’s Disease at CTADNASDAQ:CGTXCognition Therapeutics Inc
25/10/202307:30GlobeNewswire Inc.Cognition Therapeutics Presents Complete EEG Findings from SEQUEL Study of CT1812 in Mild-to-Moderate Alzheimer’s Disease at CTADNASDAQ:CGTXCognition Therapeutics Inc
16/10/202322:30GlobeNewswire Inc.Cognition Therapeutics Presents New Data at CTAD Conference from Advancing Pipeline Across Multiple CNS IndicationsNASDAQ:CGTXCognition Therapeutics Inc
12/09/202321:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CGTXCognition Therapeutics Inc
07/09/202321:45GlobeNewswire Inc.Cognition Therapeutics Announces New Conversations Episode on Therapeutic Strategies to Protect the Retina in Dry AMDNASDAQ:CGTXCognition Therapeutics Inc
30/08/202322:00GlobeNewswire Inc.Cognition Therapeutics Announces Participation in Upcoming September ConferencesNASDAQ:CGTXCognition Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CGTX